Position in BCRX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$11,740,520
-$656,966 QoQ
Shares Held
1,174,052
-9.8% QoQ
Ownership
0.459%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#47
of 316 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in BCRX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026BNP PARIBAS ARBITRAGE, SA holds $502,986,525 across 54 Drug Manufacturers - Specialty & Generic names. BCRX ranks #11 (2.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
1,415,471 | $101,715,746 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
260,605 | $43,922,366 | |
| 3 | RDY |
Dr Reddys Laboratories Ltd
|
2,649,866 | $38,396,558 | |
| 4 | ALKS |
Alkermes plc.
|
655,140 | $34,329,336 | |
| 5 | LNTH |
Lantheus Holdings, Inc.
|
300,967 | $33,389,278 | |
| 6 | UTHR |
UNITED THERAPEUTICS Corp
|
58,580 | $31,740,401 | |
| 7 | ELAN |
Elanco Animal Health Inc
|
1,180,709 | $29,057,248 | |
| 8 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
437,192 | $27,958,428 |
All Filings in BCRX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,740,520 | 1,174,052 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $12,397,486 | 1,302,257 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $19,833,169 | 2,542,714 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $15,895,570 | 2,094,278 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $13,053,438 | 1,456,857 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $942,202 | 125,627 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $1,475,612 | 196,225 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $3,775,558 | 496,784 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $536,708 | 86,846 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $852,332 | 167,782 | Shares | Defined | 2024-05-01 | |
| 2023-12-31 | $4,733,076 | 790,163 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $3,844,213 | 542,968 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $1,518,823 | 215,742 | Shares | Defined | 2023-08-09 | |
| 2023-03-31 | $2,838,860 | 340,391 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $1,797,458 | 156,573 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $3,022,488 | 239,880 | Shares | Defined | 2022-11-16 | |
| 2022-06-30 | $430,415 | 40,682 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $420,239 | 25,845 | Shares | Defined | 2022-05-18 | |
| 2021-12-31 | $912,105 | 65,856 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $630,900 | 43,904 | Shares | Defined | 2021-11-16 | |
| 2021-06-30 | $264,864 | 16,753 | Shares | Defined | 2021-08-10 | |
| 2021-03-31 | $310,673 | 30,548 | Shares | Defined | 2021-05-07 | |
| 2020-12-31 | $139,814 | 18,767 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $141,741 | 41,204 | Shares | Defined | 2020-10-30 | |
| 2020-06-30 | $170,108 | 35,737 | Shares | Defined | 2020-08-06 | |
| 2020-03-31 | $141,034 | 70,517 | Shares | Defined | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||